• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Did Geron's Big Announcement Just Go Unnoticed?

cafead

Administrator
Staff member
  • cafead   May 16, 2019 at 07:02: PM
via Shares of the clinical-stage biotech Geron Corporation (NASDAQ: GERN) fell by as much as 7% today in response to a broad corporate update. What's got investors riled up?

article source
 

<